IRIS
ORLANDONI, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.769
EU - Europa 857
AS - Asia 297
AF - Africa 41
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.967
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.767
UA - Ucraina 225
SE - Svezia 128
IT - Italia 121
IE - Irlanda 118
TR - Turchia 98
DE - Germania 96
DK - Danimarca 87
CN - Cina 75
SG - Singapore 74
FI - Finlandia 48
KR - Corea 46
CI - Costa d'Avorio 36
GB - Regno Unito 19
BE - Belgio 5
FR - Francia 5
MA - Marocco 5
CH - Svizzera 3
IN - India 3
CA - Canada 2
CL - Cile 2
BG - Bulgaria 1
EU - Europa 1
JP - Giappone 1
SI - Slovenia 1
Totale 2.967
Salva come PNG Salva come JPEG
Città #
Jacksonville 233
Chandler 229
Fairfield 205
Dublin 118
Wilmington 102
Boardman 101
Ashburn 100
Woodbridge 86
Seattle 73
Houston 71
New York 61
Ann Arbor 52
Cambridge 51
Lawrence 47
Princeton 47
San Mateo 47
Turin 47
Abidjan 36
Singapore 25
San Diego 20
Des Moines 15
Beijing 9
Centro 9
Izmir 8
Shanghai 8
Buffalo 7
Falls Church 7
Guangzhou 7
Wuhan 6
Ancona 5
Brussels 5
London 5
Naples 5
Norwalk 4
Wuxi 4
Campobasso 3
Dallas 3
Helsinki 3
Kilburn 3
Pune 3
Redmond 3
San Jose 3
Zurich 3
Chiswick 2
Clifton 2
Los Angeles 2
Ottawa 2
Palermo 2
Scandicci 2
Simi Valley 2
Vallefoglia 2
Venice 2
Washington 2
Acton 1
Auburn Hills 1
East Los Angeles 1
Hangzhou 1
Islington 1
Jiaxing 1
Jinan 1
Kunshan 1
La Canada Flintridge 1
Ljubljana 1
Longyan 1
Macerata 1
Nanjing 1
North Bergen 1
Ozzano Monferrato 1
Pesaro 1
Porto 1
Prescot 1
Seoul 1
Solon 1
Tiantai Chengguanzhen 1
Yiwu 1
Totale 1.921
Salva come PNG Salva come JPEG
Nome #
BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci. 129
Cecropin B enhances betalactams activities in experimental rat models of gram-negative septic shock 89
Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides 86
Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models. 81
Temporin A is effective in MRSA-infected wounds through bactericidal activity and acceleration of wound repair in a murine model. 81
Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. 78
Daptomycin and Rifampin Alone and in Combination Prevent Vascular Graft Biofilm Formation and Emergence of Antibiotic Resistance in a Subcutaneous Rat Pouch Model of Staphylococcal Infection. 77
IB-367 pre-treatment improves the in vivo efficacy of teicoplanin and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus 76
Antiendotoxin activity of antimicrobial peptides and glycopeptides. 75
Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis. 74
Efficacy of Tigecycline and Rifampin Alone and in Combination against Enterococcus faecalis Biofilm Infection in a Rat Model of Ureteral Stent. 74
EFFECT OF PLATELET RICH PLASMA CONCENTRATION ON SKELETAL MUSCLE REGENERATION: AN EXPERIMENTAL STUDY 73
Lipopeptide Laur-CKK-NH2 dimer preserves daptomycin susceptibility and enhances its activity against Enterococcus faecalis. 72
Vitamin E supplementation in old mice induces antimicrobial activity and improves the efficacy of daptomycin in an animal model of wounds infected with methicillin resistant Staphylococcus aureus. 70
Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria. 70
Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock 69
Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats. 68
Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock 68
Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain. 67
Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection. 67
Effects of the antimicrobial peptide BMAP-27 in a mouse model of obstructive jaundice stimulated by lipopolysaccharide 66
Distinctin improves the efficacies of glycopeptides and betalactams against staphylococcal biofilm in an experimental model of central venous catheter infection. 66
Comparative efficacy of quinupristin/dalfopristin, linezolid, vancomycin and ciprofloxacin in the treatment of experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock technique 64
Efficacy of quinupristin/dalfopristin in preventing vascular graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides. 64
Potential application of berberine in the treatment of Escherichia coli sepsis 61
LL-37 protects rats against lethal sepsis caused by gram-negative bacteria. 60
Vitamin E improves the in vivo efficacy of tigecycline and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus. 60
Temporin A soaking in combination with intraperitoneal linezolid prevents vascular graft infection in a subcutaneous rat pouch model of infection with Staphylococcus epidermidis with intermediate resistance to glycopeptides. 60
Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to a multiresistant Pseudomonas aeruginosa strain. 59
Experimental study on the efficacy of combination of alpha-helical antimicrobial peptides and vancomycin against Staphylococcus aureus with intermediate resistance to glycopeptides. 59
New evidence and insights on dalbavancin and wound healing in a mouse model of skin infection 59
The lipopeptides Pal-Lys-Lys-NH(2) and Pal-Lys-Lys soaking alone and in combination with intraperitoneal vancomycin prevent vascular graft biofilm in a subcutaneous rat pouch model of staphylococcal infection 57
RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections. 54
Prophylaxis against Staphylococcus aureus vascular graft infection with mupirocin-soaked, collagen-sealed dacron. 54
Single-dose intraperitoneal magainins improve survival in a gram-negative-pathogen septic shock rat model. 53
RNAIII-inhibiting peptide and/or nisin inhibit experimental vascular graft infection with methicillin-susceptible and methicillin-resistant Staphylococcus epidermidis. 53
Pretreatment with the protegrin IB-367 affects Gram-positive biofilm and enhances the therapeutic efficacy of linezolid in animal models of central venous catheter infection. 53
The cathelicidin-derived tritrpticin enhances the efficacy of ertapenem in experimental rat models of septic shock 52
Therapeutic efficacy of intraperitoneal polymyxin B and polymyxin-like peptides alone or combined with levofloxacin in rat models of septic shock 52
Therapeutic efficacy of the polymyxin-like peptide ranalexin in an experimental model of endotoxemia. 51
Prophylactic efficacy of linezolid alone or combined with levofloxacin and vancomycin in a rat subcutaneous pouch model of graft infection caused by Staphylococcus epidermidis with intermediate resistance to glycopeptides. 51
RNA III inhibiting peptide inhibits in vivo biofilm formation by drug-resistant Staphylococcus aureus. 50
RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis. 48
Mupirocin prophylaxis against methicillin-susceptible, methicillin-resistant, or vancomycin-intermediate Staphylococcus epidermidis vascular-graft infection. 45
Temporin A as a prophylactic agent against methicillin sodium-susceptible and methicillin sodium-resistant Staphylococcus epidermidis vascular graft infection. 44
Quinupristin/dalfopristin bonding in combination with intraperitoneal antibiotics prevent infection of knitted polyester graft material in a subcutaneous rat pouch model infected with resistant Staphylococcus epidermidis. 43
Potential therapeutic role of histatin derivative P-113d in experimental rat models of Pseudomonas aeruginosa sepsis. 41
Totale 3.023
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.664
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.664
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020271 0 0 44 3 46 1 44 0 46 7 5 75
2020/2021762 53 76 103 12 74 60 87 53 72 63 69 40
2021/2022395 31 89 0 4 6 38 23 13 26 65 18 82
2022/2023668 67 84 55 44 49 77 0 28 163 3 81 17
2023/2024334 67 13 15 57 57 80 3 4 0 3 5 30
2024/2025172 115 57 0 0 0 0 0 0 0 0 0 0
Totale 3.023